Skip to main content

Table 1 Characteristics of participants in the genome-wide association cohorts

From: Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression

Disease categories

HBV clearance

ASPI

CHB

DC

HCC

HC

Sample size

275

92

93

188

214

169

Mean age ± SD

49.56 ± 8.8

46.89 ± 6.9 *

46.46 ± 5.7 **

50.65 ± 8.4

51.34 ± 10.5 *

48.82 ± 7.1

Male/female

105/170

33/59

62/31 ***

148/40 ***

183/31 ***

73/96

ALT, U/L, mean ± SD

26.95 ± 30.42

24.5 ± 8.79

169.53 ± 243.76 ***

89.57 ± 115.79 ***

214 ± 381.67 **

23.11 ± 7.97

AST, U/L, mean ± SD

25.89 ± 21.89 *

23.16 ± 6.45

100.04 ± 127.54 ***

102.46 ± 118.36 ***

120.51 ± 286.05 ***

22.23 ± 7.00

TBiL, μmol/L, mean ± SD

13.68 ± 9.93

12.28 ± 2.91

23.12 ± 35.60 ***

65.87 ± 83.22 ***

50.11 ± 90.93 ***

12.95 ± 4.09

DBiL, μmol/L, mean ± SD

5.86 ± 18.39

3.59 ± 1.68

9.36 ± 14.29 **

35.15 ± 51.33 ***

25.87 ± 55.04 ***

4.54 ± 9.46

ALP, U/L, mean ± SD

74.30 ± 35.86

73.57 ± 44.58

108.89 ± 42.20 ***

132.22 ± 61.42 ***

141.63 ± 104.32 ***

70.85 ± 25.33

GGT, U/L, mean ± SD

28.34 ± 30.77

29.88 ± 21.19

88.76 ± 106.63 ***

89.94 ± 132.10 ***

158.08 ± 183.92 ***

27.58 ± 24.88

ALB, g/L, mean ± SD

43.33 ± 6.11

44.16 ± 6.71

42.40 ± 42.25 *

32.28 ± 7.13 **

37.19 ± 7.27 ***

43.93 ± 4.96

AFP, μg/L, mean ± SD

21.39 ± 47.39 *

5.16 ± 4.79

34.00 ± 89.37 *

87.74 ± 169.83 **

7315.22 ± 37,329.94

3.76 ± 4.34

PTA, %, mean ± SD

95.22 ± 52.69

91.67 ± 14.30

90.06 ± 21.76

63.97 ± 28.07 ***

87.31 ± 33.96

90.84 ± 18.71

PLT, 109/L, mean ± SD

147.69 ± 55.40

146.84 ± 44.51

150.27 ± 49.61

73.96 ± 45.30 ***

145.72 ± 79.24

148.94 ± 49.10

  1. Abbreviations: ASPI, asymptomatic persistence infection; CHB, chronic hepatitis B; DC, decompensated cirrhosis; HCC, hepatocellular carcinoma; HC, healthy controls; SD, standard deviation; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TBIL, total bilirubin; DBIL, direct bilirubin; ALP, alkaline phosphatase; GGT, glutamyl transpeptidase
  2. Notes: *, statistical significance of the difference between each case group and HC group (***: p = [0, 0.001], **: p = (0.001, 0.01], *: p = (0.01, 0.05]). The significances of gender and other characteristics were calculated by Fisher's exact test and ANOVA test, respectively